25 results on '"Warren, R. B."'
Search Results
2. Secukinumab improves the quality‐of‐life of family members and partners of people with psoriasis: Family Dermatology Life Quality Index (FDLQI) results from a randomised open‐label study (SIGNATURE)
3. Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE‐2 and ‐3
4. Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3
5. Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge):Results from a phase 3, randomised, open-label, efficacy assessor-blinded clinical trial
6. Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis:pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks
7. Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: Comment on the article by Wessels et al
8. Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy
9. Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the UK and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
10. Comprehensive Long-Term Safety of Adalimumab from Eighteen Clinical Trials in Adult Patients With Moderate to Severe Plaque Psoriasis
11. Polymorphisms in Methotrexate Efflux Transporters have the Potential to Predict Clinical Response to Methotrexate Therapy in Psoriasis
12. Polymorphisms in the PTPN22 Region are Associated with Psoriasis of Early Onset
13. Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland:results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
14. Demographics and disease characteristics of psoriasis patients enrolled in the British Association of Dermatologists Biologic Interventions Register (BADBIR)
15. A novel mutation in IL36RN underpins childhood pustular dermatosis
16. Genetic susceptibility to psoriasis and psoriatic arthritis: Implications for therapy
17. The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases
18. World War Debt Settlements. Harold G. Moulton Leo Pasvolsky
19. Total body surface potential mapping during exercise: QRS-T-wave changes in normal young adults.
20. Body surface low-level potentials during ventricular repolarization with analysis of the ST segment: variability in normal subjects.
21. Isopotential body surface mapping in subjects of all ages: emphasis on low-level potentials with analysis of the method.
22. Extracellular potentials related to intracellular action potentials during impulse conduction in anisotropic canine cardiac muscle.
23. Credit Policies of the Federal Reserve System Charles O. Hardy
24. Papillary cystic tumor of the pancreas.
25. An attempt at perspective.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.